United Therapeutics Corporation Interest Expense
United Therapeutics Corporation (UTHR) reported Interest Expense of $13.30 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-01
- United Therapeutics Corporation interest expense for the quarter ending 2024-03-31 was $13.30M, a 3.62% decline year-over-year.
- United Therapeutics Corporation interest expense for the quarter ending 2023-12-31 was $15.10M, a 22.76% increase year-over-year.
- United Therapeutics Corporation interest expense for the quarter ending 2023-09-30 was $15.60M, a 69.57% increase year-over-year.
- United Therapeutics Corporation interest expense for the quarter ending 2023-06-30 was $14.80M, a 138.71% increase year-over-year.
- United Therapeutics Corporation interest expense for fiscal 2023 was $59.30M, a 83.02% increase from fiscal 2022.
- United Therapeutics Corporation interest expense for fiscal 2022 was $32.40M, a 74.19% increase from fiscal 2021.
- United Therapeutics Corporation interest expense for fiscal 2021 was $18.60M, a 20.85% decline from fiscal 2020.
- United Therapeutics Corporation interest expense for fiscal 2020 was $23.50M, a 46.83% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $13.30M 10-Q · filed 2024-05-01 | $28.40M derived: sum of 2 quarters · filed 2024-05-01 | $44.00M derived: sum of 3 quarters · filed 2024-05-01 | $58.80M derived: sum of 4 quarters · filed 2024-05-01 | ||||
| 2023-12-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $30.70M derived: sum of 2 quarters · filed 2024-02-21 | $45.50M derived: sum of 3 quarters · filed 2024-02-21 | $59.30M 10-K · filed 2024-02-21 | ||||
| 2023-09-30 | $15.60M 10-Q · filed 2023-11-01 | $30.40M derived: sum of 2 quarters · filed 2023-11-01 | $44.20M 10-Q · filed 2023-11-01 | $56.50M derived: sum of 4 quarters · filed 2024-05-01 | ||||
| 2023-06-30 | $14.80M 10-Q · filed 2023-08-02 | $28.60M 10-Q · filed 2023-08-02 | $40.90M derived: sum of 3 quarters · filed 2024-05-01 | $50.10M derived: sum of 4 quarters · filed 2024-05-01 | ||||
| 2023-03-31 | $13.80M 10-Q · filed 2024-05-01 | $26.10M derived: sum of 2 quarters · filed 2024-05-01 | $35.30M derived: sum of 3 quarters · filed 2024-05-01 | $41.50M derived: sum of 4 quarters · filed 2024-05-01 | ||||
| 2022-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $21.50M derived: sum of 2 quarters · filed 2024-02-21 | $27.70M derived: sum of 3 quarters · filed 2024-02-21 | $32.40M 10-K · filed 2024-02-21 | ||||
| 2022-09-30 | $9.20M 10-Q · filed 2023-11-01 | $15.40M derived: sum of 2 quarters · filed 2023-11-01 | $20.10M 10-Q · filed 2023-11-01 | $24.80M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $6.20M 10-Q · filed 2023-08-02 | $10.90M 10-Q · filed 2023-08-02 | $15.60M derived: sum of 3 quarters · filed 2024-02-21 | $20.20M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $4.70M 10-Q · filed 2023-05-03 | $9.40M derived: sum of 2 quarters · filed 2024-02-21 | $14.00M derived: sum of 3 quarters · filed 2024-02-21 | $18.70M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $9.30M derived: sum of 2 quarters · filed 2024-02-21 | $14.00M derived: sum of 3 quarters · filed 2024-02-21 | $18.60M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $4.60M 10-Q · filed 2022-11-02 | $9.30M derived: sum of 2 quarters · filed 2022-11-02 | $13.90M 10-Q · filed 2022-11-02 | $18.70M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $4.70M 10-Q · filed 2022-08-03 | $9.30M 10-Q · filed 2022-08-03 | $14.10M derived: sum of 3 quarters · filed 2023-02-22 | $19.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $4.60M 10-Q · filed 2022-05-04 | $9.40M derived: sum of 2 quarters · filed 2023-02-22 | $14.30M derived: sum of 3 quarters · filed 2023-02-22 | $19.90M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $9.70M derived: sum of 2 quarters · filed 2023-02-22 | $15.30M derived: sum of 3 quarters · filed 2023-02-22 | $23.50M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $4.90M 10-Q · filed 2021-11-03 | $10.50M derived: sum of 2 quarters · filed 2021-11-03 | $18.70M 10-Q · filed 2021-11-03 | $28.70M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $5.60M 10-Q · filed 2021-08-04 | $13.80M 10-Q · filed 2021-08-04 | $23.80M derived: sum of 3 quarters · filed 2022-02-24 | $35.50M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $8.20M 10-Q · filed 2021-05-05 | $18.20M derived: sum of 2 quarters · filed 2022-02-24 | $29.90M derived: sum of 3 quarters · filed 2022-02-24 | $42.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $21.70M derived: sum of 2 quarters · filed 2022-02-24 | $33.90M derived: sum of 3 quarters · filed 2022-02-24 | $44.20M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $11.70M 10-Q · filed 2020-10-28 | $23.90M derived: sum of 2 quarters · filed 2020-10-28 | $34.20M 10-Q · filed 2020-10-28 | $38.50M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $12.20M 10-Q · filed 2020-07-29 | $22.50M 10-Q · filed 2020-07-29 | $26.80M derived: sum of 3 quarters · filed 2021-02-24 | $30.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $10.30M 10-Q · filed 2020-04-29 | $14.60M derived: sum of 2 quarters · filed 2021-02-24 | $18.70M derived: sum of 3 quarters · filed 2021-02-24 | $21.60M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $8.40M derived: sum of 2 quarters · filed 2021-02-24 | $11.30M derived: sum of 3 quarters · filed 2021-02-24 | $13.90M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $4.10M 10-Q · filed 2019-10-30 | $7.00M derived: sum of 2 quarters · filed 2019-10-30 | $9.60M 10-Q · filed 2019-10-30 | $13.10M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.90M 10-Q · filed 2019-07-31 | $5.50M 10-Q · filed 2019-07-31 | $9.00M derived: sum of 3 quarters · filed 2020-02-26 | $12.30M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $2.60M 10-Q · filed 2019-05-01 | $6.10M derived: sum of 2 quarters · filed 2020-02-26 | $9.40M derived: sum of 3 quarters · filed 2020-02-26 | $10.80M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $6.80M derived: sum of 2 quarters · filed 2020-02-26 | $8.20M derived: sum of 3 quarters · filed 2020-02-26 | $9.00M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $3.30M 10-Q · filed 2018-10-31 | $4.70M derived: sum of 2 quarters · filed 2018-10-31 | $5.50M 10-Q · filed 2018-10-31 | $7.70M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.40M 10-Q · filed 2018-08-01 | $2.20M 10-Q · filed 2018-08-01 | $4.40M derived: sum of 3 quarters · filed 2019-02-27 | $4.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $800.00K 10-Q · filed 2018-05-02 | $3.00M derived: sum of 2 quarters · filed 2019-02-27 | $3.50M derived: sum of 3 quarters · filed 2019-02-27 | $4.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.70M derived: sum of 2 quarters · filed 2019-02-27 | $3.30M derived: sum of 3 quarters · filed 2019-02-27 | $3.90M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $500.00K 10-Q · filed 2017-10-25 | $1.10M derived: sum of 2 quarters · filed 2017-10-25 | $1.70M 10-Q · filed 2017-10-25 | $2.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $600.00K 10-Q · filed 2017-07-27 | $1.20M 10-Q · filed 2017-07-27 | $1.70M derived: sum of 3 quarters · filed 2018-02-21 | $2.50M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $600.00K 10-Q · filed 2017-04-26 | $1.10M derived: sum of 2 quarters · filed 2018-02-21 | $1.90M derived: sum of 3 quarters · filed 2018-02-21 | $3.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $1.30M derived: sum of 2 quarters · filed 2018-02-21 | $2.60M derived: sum of 3 quarters · filed 2018-02-21 | $4.70M 10-K · filed 2018-02-21 | $4.74M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $800.00K 10-Q · filed 2016-10-27 | $834.00K 10-Q · filed 2015-10-27 | $2.10M derived: sum of 2 quarters · filed 2016-10-27 | $4.20M 10-Q · filed 2016-10-27 | $4.19M 10-Q · filed 2015-10-27 | $7.74M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-06-30 | $1.30M 10-Q · filed 2016-07-28 | $1.30M 10-Q · filed 2015-07-28 | $3.40M 10-Q · filed 2016-07-28 | $3.35M 10-Q · filed 2015-07-28 | $6.93M derived: sum of 3 quarters · filed 2017-02-22 | $11.64M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | $2.10M 10-Q · filed 2016-04-28 | $2.06M 10-Q · filed 2015-04-28 | $5.63M derived: sum of 2 quarters · filed 2017-02-22 | $10.34M derived: sum of 3 quarters · filed 2017-02-22 | $15.09M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $8.24M derived: sum of 2 quarters · filed 2017-02-22 | $12.99M derived: sum of 3 quarters · filed 2017-02-22 | $17.60M 10-K · filed 2017-02-22 | $17.59M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $4.71M 10-Q · filed 2015-10-27 | $9.46M derived: sum of 2 quarters · filed 2015-10-27 | $14.06M 10-Q · filed 2015-10-27 | $18.63M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $4.75M 10-Q · filed 2015-07-28 | $9.36M 10-Q · filed 2015-07-28 | $13.92M derived: sum of 3 quarters · filed 2016-02-25 | $18.46M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $4.61M 10-Q · filed 2015-04-28 | $9.17M derived: sum of 2 quarters · filed 2016-02-25 | $13.71M derived: sum of 3 quarters · filed 2016-02-25 | $18.23M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $9.10M derived: sum of 2 quarters · filed 2016-02-25 | $13.62M derived: sum of 3 quarters · filed 2016-02-25 | $18.06M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $4.54M 10-Q · filed 2014-10-28 | $9.06M derived: sum of 2 quarters · filed 2014-10-28 | $13.50M 10-Q · filed 2014-10-28 | $17.99M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $4.52M 10-Q · filed 2014-07-29 | $8.96M 10-Q · filed 2014-07-29 | $13.45M derived: sum of 3 quarters · filed 2015-02-24 | $17.83M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $4.44M 10-Q · filed 2014-04-29 | $8.93M derived: sum of 2 quarters · filed 2015-02-24 | $13.31M derived: sum of 3 quarters · filed 2015-02-24 | $17.19M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $8.87M derived: sum of 2 quarters · filed 2015-02-24 | $12.75M derived: sum of 3 quarters · filed 2015-02-24 | $16.64M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $4.38M 10-Q · filed 2013-10-29 | $8.26M derived: sum of 2 quarters · filed 2013-10-29 | $12.15M 10-Q · filed 2013-10-29 | $17.26M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $3.88M 10-Q · filed 2013-07-25 | $7.76M 10-Q · filed 2013-07-25 | $12.88M derived: sum of 3 quarters · filed 2014-02-25 | $18.29M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $3.89M 10-Q · filed 2013-04-25 | $9.00M derived: sum of 2 quarters · filed 2014-02-25 | $14.41M derived: sum of 3 quarters · filed 2014-02-25 | $19.84M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $10.53M derived: sum of 2 quarters · filed 2014-02-25 | $15.96M derived: sum of 3 quarters · filed 2014-02-25 | $21.37M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $5.42M 10-Q · filed 2012-11-01 | $10.85M derived: sum of 2 quarters · filed 2012-11-01 | $16.26M 10-Q · filed 2012-11-01 | $21.71M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $5.43M 10-Q · filed 2012-07-26 | $10.84M 10-Q · filed 2012-07-26 | $16.30M derived: sum of 3 quarters · filed 2013-02-26 | $21.11M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $5.41M 10-Q · filed 2012-04-26 | $5.41M 10-Q · filed 2011-04-28 | $10.87M derived: sum of 2 quarters · filed 2013-02-26 | $15.67M derived: sum of 3 quarters · filed 2013-02-26 | $20.43M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $10.26M derived: sum of 2 quarters · filed 2013-02-26 | $15.02M derived: sum of 3 quarters · filed 2013-02-26 | $19.71M 10-K · filed 2013-02-26 | $19.71M 10-K · filed 2011-02-24 | |||
| 2010-09-30 | $4.81M 10-Q · filed 2011-10-27 | $9.57M derived: sum of 2 quarters · filed 2011-10-27 | $14.26M 10-Q · filed 2011-10-27 | $17.91M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-06-30 | $4.76M 10-Q · filed 2011-07-28 | $9.45M 10-Q · filed 2011-07-28 | $13.11M derived: sum of 3 quarters · filed 2012-02-28 | $16.44M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-03-31 | $4.69M 10-Q · filed 2011-04-28 | $8.35M derived: sum of 2 quarters · filed 2012-02-28 | $11.68M derived: sum of 3 quarters · filed 2012-02-28 | $14.93M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $6.99M derived: sum of 2 quarters · filed 2012-02-28 | $10.24M derived: sum of 3 quarters · filed 2012-02-28 | $12.88M 10-K · filed 2012-02-28 | ||||
| 2009-09-30 | $3.33M 10-Q · filed 2010-10-28 | $6.58M derived: sum of 2 quarters · filed 2010-10-28 | $9.22M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $3.25M 10-Q · filed 2010-07-28 | $5.88M 10-Q · filed 2010-07-28 | ||||||
| 2008-12-31 | $11.44M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |